This week a decision should be made by the FDA on a new gene therapy, betibeglogene autotemcel (beti-cel). Beti-cel is a one-time autologous product designed to treat transfusion-dependent beta thalassemia.
Read moreStudy Results of Dostarlimab-gxly for Locally Advanced Rectal Cancer
Clinical trial data published in the New England Medical Journal on June 23, 2022, reveal that locally advanced rectal cancer stage II or III with dMMR is sensitive to drug Dostarlimab-gxly.
Read moreStudy results of Enhertu and HER-2 for Metastatic Breast Cancer
For the first time, a targeted medicine can help metastatic breast cancer patients whose tumors express only low levels of HER2.
Read moreSummit Re Announces Loss of Key Staff Member
We are saddened to announce the passing of our good friend and colleague, Jack Snyder, on Sunday, April 24, 2022. Jack joined Summit Re in 2011 and served as regional vice president for our employer stop loss team until the time of his death. Jack will be deeply missed.
Jack’s obituary may be found at https://www.cloverdalefuneralhome.com/tributes/Jack-Snyder.
Update: Expanded Criteria Organ Transplants
For people awaiting a transplant, expanded criteria donor (ECD) organs may bridge the gap between life and death. ECD availability can separate those on the waiting list from those who will die before receiving their needed organ.
Read moreMary Sullivan Joins Summit Re's Sales Team
Summit Reinsurance Services, Inc. has named Mary Sullivan to the position of vice president, sales.
Read moreFDA Approval of Aduhelm (Aducanumab) for Alzheimer's Disease
On June 7, 2021 the FDA approved Aduhelm (aducanumab) for the treatment of Alzheimer’s. The first new treatment in over 17 years, its approval has not come without controversy.
Read moreSummit Re Makes Key Addition to Sales Team
Summit Reinsurance Services, Inc. has named Scott Machut, CPA, FLMI to the position of vice president of reinsurance and provider excess sales.
Read moreKathy Clark to Lead Summit ReSources
Summit Reinsurance Services, Inc. has elevated Kathy Clark, RN, BSN, CMCN, to assistant vice president and director of managed care effective May 31, 2021. With this promotion, Clark assumes responsibility for Summit ReSources, Summit Re’s medical management program, and its staff.
Read moreCell and Gene Therapies: Navigating a Challenging Landscape
Cell and gene therapy will most certainly continue to shift paradigms for manufacturers, patients, healthcare providers and pharmacies for many years. These are groundbreaking technologies which offer hope to millions of individuals that previously had no viable options for treatment or cure.
Read more